X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Global Orphan Drugs Companies

This report lists the top Global Orphan Drugs companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Global Orphan Drugs industry.

Single User License

$5500

Team License

$6000

Corporate License

$9500

Book before:

Single User License

$5500

Team License

$6000

Corporate License

$9500

Book before:

Global Orphan Drugs Top Companies

  1. Takeda Pharmaceuticals

  2. Novartis

  3. Johnson & Johnson

  4. Roche

  5. Bristol-Myers Squibb

*Disclaimer: Top companies sorted in no particular order

Global Orphan Drugs Market Major Players

Global Orphan Drugs Market Concentration

Global Orphan Drugs  Market Concentration

Global Orphan Drugs Company List

                              • Alexion Pharmaceuticals

                              • Bristol-Myers Squibb Company (Celgene Corporation)

                              • Novartis AG

                              • Pfizer Inc.

                              • F. Hoffmann-La Roche Ltd

                              • Takeda Pharmaceutical Company Limited

                              • Amgen Inc.

                              • Sanofi S.A

                              • Johnson & Johnson

                              • AstraZeneca Plc

                              • AbbVie Inc.

                              • GlaxoSmithKline Plc

                              • Daiichi Sankyo Company Limited

                              • Bayer AG


                          Specific to Global Orphan Drugs Market
                          Need More Details On Market Players And Competitors?
                          Download PDF

                          Orphan Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)